Episode 322 ASCO24: The role of ctDNA in the TheraP trial (LuPSMA vs cabazitaxel in CRPC)

The Uromigos - En podkast av The Uromigos

Prøv Podimo gratis i hele 60! dager!

I Podimo finner du eksklusive podkaster og bestselgende lydbøker tilpasset dine ører

Alex Wyatt describes the predictive resistance of ctDNA fraction at baseline in predicting outcome.